GlassScriptPhysician profile
Matthew C Grothaus
NPI 1417978776
$4,514.17
in general payments reported to CMS, 2019-2025
18 companies · $1,549 in 2025
The $1,549 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $741 · 2020: $332 · 2021: $585 · 2022: $157 · 2023: $1,131 · 2024: $18.35 · 2025: $1,549.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,315 · Food and Beverage: $384.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,314.61 |
| Food and Beverage | $383.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,146.80 | 2019-2025 | Collagenase Santyl, Regranex |
| Zimmer Biomet Holdings, INC. | $1,031.98 | 2023 | Avenir, Anterior Supine Stem Extractor |
| Arthrex, INC. | $889.32 | 2025 | |
| Nexus Medical Technologies LLC | $569.29 | 2025 | |
| Catalyst Orthoscience | $407.80 | 2021 | |
| Anika Therapeutics, INC. | $81.87 | 2023 | Tactoset |
| Bioventus LLC | $74.09 | 2020-2025 | Gelsyn-3 |
| Depuy Synthes Sales INC. | $70.14 | 2021-2022 | |
| Heron Therapeutics, INC. | $48.26 | 2022 | |
| Pacira Therapeutics, INC. | $37.90 | 2019 | |
| Ferring Pharmaceuticals INC. | $28.95 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $24.00 | 2025 | |
| Stryker Corporation | $23.45 | 2022 | |
| Kci USA, INC. | $19.19 | 2022 | |
| Crossroads Orthopedics, LLC | $16.80 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $16.15 | 2022 | |
| Innovation Technologies INC | $15.63 | 2025 | Irrisept |
| Biocomposites INC | $12.55 | 2025 | Stimulan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Grothaus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.